WE WILL JOIN THE 26TH EUROPEAN CONGRESS OF PSYCHIATRY IN NICE, FRANCE, MARCH 3-6 2018

Presenters at the conference:

  • Jesper Nørgaard Kjær: Workforce migration in the Scandinavian countries – do trainees still want to leave from what is perceived by everyone else as the paradise? (e-Poster Walk)
  • Christopher Rohde: Real-world Effectiveness of Clozapine for Mental Retardation: Results from a Mirror-image and a Reverse-mirror-image Study (ePoster Walk)
  • Clara Reece Medici: Typical and atypical antipsychotics in acute mania: Comparison of effectiveness (ePoster)
  • Astrid Harpøth: A preclinical assessment of the antidepressant-like effect of Isoflurane (ePoster)
  • Amalie Bach Dybdal: Can doctors apply treatment strategies for patients with bodily distress syndrome (ePoster)

NEW PUBLICATION

Christopher Rohde investigated the effects of clozapine in borderline personality disorder. Clozapine was associated with a reduction in psychiatric admissions from 2.52 (95%-CI 2.31-2.78) to 2.00 (95%-CI 1.77-2.23) admissions and a reduction in psychiatric bed-days from 190.08 (95%-CI 176.84-203.33) to 65.95 (95%-CI 58.27-73.66) bed-days. Further, the number of patients with intentional self-harm or overdose decreased significantly from 189 to 114 individuals after clozapine initiation. Read more here.

NEW PUBLICATION

Clara Reece Medici co-authored a study on quality of life and physical health in patients with schizophrenia. The authors found that patients with schizophrenia presented with low quality of life and elevated risk factors for poor physical health. Life style intervention added onto ‘treatment as usual’ improved some risk factors for poor physical health among long-term patients. The number of interventions had an elevating effect on quality of life. Read more here.